Phase II study of weekly Vinorelbine and Topotecan administration treatment for refractory adult rhabdomyosarcoma previously treated by VAC regime
Phase 2
Recruiting
- Conditions
- Adult rhabdomyosarcoma with prior VAC therapy
- Registration Number
- JPRN-UMIN000008202
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Not provided
Exclusion Criteria
a) pregancy b) sereve infection c) interstitual pneumonia or lung fibrosis d) symptomatic CNS metastases e) HIV infection f) nuerotoxicity with >= grade 3
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Progression-free survival Overall survival Adverse events